The expression of vascular endothelial growth factor (VEGF)/endostatin (ES) and VEGF receptor 2 (VEGFR2)/ES is associated with NSCLC prognosis

被引:2
作者
Yuan Yang [1 ]
Baohua Lu [1 ]
Baolan Li [1 ]
Weiying Li [2 ]
Mei Jiang [2 ]
Wentao Yue [2 ]
Qunhui Wang [1 ]
Tongmei Zhang [1 ]
机构
[1] General Department of Medicine, Beijing Chest Hospital, Capital Medical University
[2] Laboratory of Cell Biotechnology, Beijing Tuberculosis and Thoracic Tumor Research Institute
关键词
non-small cell lung cancer(NSCLC); angiogenesis; clinical characteristics; prognosis;
D O I
暂无
中图分类号
R734.2 [肺肿瘤];
学科分类号
100214 ;
摘要
Objective The aim of our study was to detect the expression of angiogenesis inhibitory proteins and angiogenesis promotive proteins in the postoperative tumor tissue of non-small cell lung cancer (NSCLC) patients.We also investigated the relationship of protein expression with clinical characteristics and prognosis.Methods We examined the expression of vascular endothelial growth factor (VEGF),VEGF receptor 2 (VEGFR2),and endostatin (ES) proteins in 255 specimens resected from NSCLC patients,using immune histochemistry (IHC).We then evaluated the relationships between the expression of the three proteins and clinical characteristics such as stage,histological type,differentiation,gender,tobacco use,and age.According to the value of VEGF/ES,we divided the cohort into angiogenesis-promoting group A,angiogenesis-inhibiting group A,and balance group A.The survival differences in the three groups were evaluated to determine the prognostic value of VEGF/ES.Similarly,we tested the prognostic value of VEGFR2/ES.Results VEGF-positive expression was observed in 93 patients (36.4%).VEGF expression was not correlated with the clinical characteristics.VEGFR2-positive expression was observed in 103 patients (40.4%).The expression of VEGFR2 was correlated with the clinical stage (χ2=21.414,P=0.045) and histological type (χ2=26.911,P=0.008).ES-positive expression was observed in 140 patients (54.9%).The expression of ES was correlated with the clinical stage (χ2=26.504,P=0.009).When evaluating the prognostic values of VEGF/ES and VEGFR2/ES,the prognosis of the angiogenesis balance group was similar to that of the angiogenesis-inhibiting group.The minimum survival time was observed in the angiogenesis-promoting group.Conclusion VEGF/ES and VEGFR2/ES in resected tumors have prognostic value in postoperative NSCLC patients.The survival time of the population with predominant angiogenic factors was short.
引用
收藏
页码:149 / 154
页数:6
相关论文
共 19 条
[1]   A retrospective analysis of the safety and efficacy of apatinib in treating advanced metastatic colorectal cancer [J].
Li Wang ;
Juan Lu ;
Yi Liu ;
Yunfei Gao ;
Man Kong ;
Jiandong Yang ;
Bin Kong ;
Xuebing Li ;
Xifen Huang ;
Wenzhong Pei .
OncologyandTranslationalMedicine, 2017, 3 (05) :210-216
[2]   重组人血管内皮抑制素联合贝伐珠单抗体内抑瘤作用的效果及分析 [J].
牛牛 ;
李宝兰 ;
刘朝阳 ;
胡瑛 ;
李雪冰 ;
李杰 ;
史鹤龄 ;
张海清 .
中国肺癌杂志, 2013, (02) :61-66
[3]   晚期恶性肿瘤血清VEGF含量测定的临床意义(英文) [J].
Yingcheng LinDe ZengHongbiao WangWenzhao LinWen LinChaoqun Hong Department of Medical OncologyThe Cancer Hospital of Shantou University Medical CollegeShantou China .
Chinese-German Journal of Clinical Oncology, 2008, (10) :611-614
[4]   Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].
Bray, Freddie ;
Ferlay, Jacques ;
Soerjomataram, Isabelle ;
Siegel, Rebecca L. ;
Torre, Lindsey A. ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2018, 68 (06) :394-424
[5]   Cancer Statistics in China, 2015 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Baade, Peter D. ;
Zhang, Siwei ;
Zeng, Hongmei ;
Bray, Freddie ;
Jemal, Ahmedin ;
Yu, Xue Qin ;
He, Jie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132
[6]   Tumors: Wounds That Do Not Heal-Redux [J].
Dvorak, Harold F. .
CANCER IMMUNOLOGY RESEARCH, 2015, 3 (01) :1-11
[7]   The VEGF pathway in lung cancer [J].
Alevizakos, Michalis ;
Kaltsas, Serafim ;
Syrigos, Konstantinos N. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (06) :1169-1181
[8]   Evidence-based role of bevacizumab in non-small cell lung cancer [J].
Vokes, E. E. ;
Salgia, R. ;
Karrison, T. G. .
ANNALS OF ONCOLOGY, 2013, 24 (01) :6-9
[9]   Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer [J].
Szarvas, Tibor ;
Laszlo, Viktoria ;
vom Dorp, Frank ;
Reis, Henning ;
Szendroei, Attila ;
Romics, Imre ;
Tilki, Derya ;
Ruebben, Herbert ;
Erguen, Sueleyman .
INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (12) :2922-2929
[10]  
Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer[J] . Carrillo de Santa Pau Enrique,Arias Fernando Carrillo,Caso Peláez Enrique,Mu?oz Molina Gemma María,Sánchez Hernández Ignacio,Muguruza Trueba Ignacio,Moreno Balsalobre Ramón,Sacristán López Silvia,Gómez Pinillos Alejandro,del Val Toledo Lobo María.Cancer . 2009 (8)